Abacus dx ANZICS/ACCCN Intensive Care 2024 Showcase
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC
Abacus dx creates value by connecting innovative global suppliers with Australasian customers. We are proud to partner with Immunexpress, to provide their revolutionary SeptiCyte™ technology aiding in sepsis diagnosis and treatment, with actionable results available in just one hour.
SeptiCyte® RAPID revolutionizes sepsis diagnosis and treatment, with actionable results available in an hour. SeptiCyte®RAPID can determine the likelihood of sepsis and differentiate from non-infectious systemic inflammatory response syndrome (SIRS) in critically ill patients. The test, which uses a small volume of blood, can be performed easily in any hospital lab with the Biocartis Idylla™ molecular testing system.
| Immunexpress | |
| Immunexpress SeptiCyte Brochure | Download Here → |
| Immunexpress Poster – Accurate Sepsis Identification Using SeptiCyte Rapid and Other Biomarkers of Systemic Inflammation | Download Here → |
| Immunexpress Poster – Performance of SeptiCyte Rapid for Determining Probability of Sepsis in Immunocompromised Patients | Download Here → |